Form EFFECT Yarrow Bioscience, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 19, 2026 |
| Accession Number: | 0001104659-26-096109 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
- SK pharmteco to Attend CPHI, Showcasing Multimodal CDMO Capabilities and Global Manufacturing Infrastructure
- Integral Consulting Services Announces Strategic Ownership Expansion and Rebrands as Integral National, Expanding Independent Medical Examination (IME) Services Nationwide
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
